XT
XTX Topco Portfolio holdings
AUM
$2.41B
1-Year Return
23.26%
This Quarter Return
+5.43%
1 Year Return
+23.26%
3 Year Return
+47.46%
5 Year Return
–
10 Year Return
–
AUM
$1.19B
AUM Growth
-$183M
(-13%)
Cap. Flow
-$194M
Cap. Flow
% of AUM
-16.31%
Top 10 Holdings %
Top 10 Hldgs %
5.4%
Holding
3,138
New
1,123
Increased
515
Reduced
566
Closed
931
Top Buys
| 1 |
UnitedHealth
UNH
|
+$9.97M |
| 2 |
Walmart
WMT
|
+$5.42M |
| 3 |
Microsoft
MSFT
|
+$5.24M |
| 4 |
Tesla
TSLA
|
+$4.92M |
| 5 |
Becton Dickinson
BDX
|
+$4.68M |
Top Sells
| 1 |
Netflix
NFLX
|
+$12.8M |
| 2 |
Visa
V
|
+$11.3M |
| 3 |
Meta Platforms (Facebook)
META
|
+$7.6M |
| 4 |
Citigroup
C
|
+$6.93M |
| 5 |
Caterpillar
CAT
|
+$5.4M |
Sector Composition
| 1 | Technology | 16.35% |
| 2 | Financials | 13.6% |
| 3 | Healthcare | 13.44% |
| 4 | Consumer Discretionary | 12.44% |
| 5 | Industrials | 12.32% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
2026
Playboy, Inc. Common Stock
PLBY
$188M
| $20.5K | ﹤0.01% |
+14,065
| New | +$20.5K |
|
2027
Urban One Class A
UONE
$64M
| $20.5K | ﹤0.01% |
13,306
+2,203
| +20% | +$3.39K |
|
2028
Imunon
IMNN
$14.2M
| $20.3K | ﹤0.01% |
+1,642
| New | +$20.3K |
|
2029
ABVC BioPharma
ABVC
$65.2M
| $20.3K | ﹤0.01% |
34,405
+11,000
| +47% | +$6.49K |
|
2030
Reading International Class A
RDI
$34.1M
| $20.3K | ﹤0.01% |
+15,371
| New | +$20.3K |
|
|
GLXG
2031
Galaxy Payroll Group Limited Class A Ordinary Shares
GLXG
$10.6M
| $20.3K | ﹤0.01% |
+20,461
| New | +$20.3K |
|
|
QNRX
2032
Quoin Pharmaceuticals
QNRX
$4.44M
| $20.2K | ﹤0.01% |
+887
| New | +$20.2K |
|
2033
Televisa
TV
$1.48B
| $20.1K | ﹤0.01% |
11,982
-52,839
| -82% | -$88.8K |
|
2034
Captivision
CAPT
$36.6M
| $20K | ﹤0.01% |
28,325
+13,594
| +92% | +$9.6K |
|
2035
Genius Group
GNS
$78.1M
| $19.9K | ﹤0.01% |
28,835
+15,349
| +114% | +$10.6K |
|
2036
Reborn Coffee
REBN
$13.2M
| $19.6K | ﹤0.01% |
+11,782
| New | +$19.6K |
|
2037
DarioHealth
DRIO
$17M
| $19.5K | ﹤0.01% |
1,239
-234
| -16% | -$3.68K |
|
2038
Outlook Therapeutics
OTLK
$48.4M
| $19.4K | ﹤0.01% |
10,244
-27,084
| -73% | -$51.2K |
|
2039
Gossamer Bio
GOSS
$787M
| $19.3K | ﹤0.01% |
+21,339
| New | +$19.3K |
|
|
AMZE
2040
Amaze Holdings, Inc.
AMZE
$15.5M
| $19.3K | ﹤0.01% |
1,441
+514
| +55% | +$6.88K |
|
2041
Solowin Holdings
SWIN
$509M
| $19.1K | ﹤0.01% |
11,573
-4,626
| -29% | -$7.63K |
|
2042
Usio Inc
USIO
$41.3M
| $19.1K | ﹤0.01% |
+13,064
| New | +$19.1K |
|
|
CLLS
2043
Cellectis
CLLS
$299M
| $18.9K | ﹤0.01% |
10,526
-2,569
| -20% | -$4.62K |
|
|
SYRS
2044
DELISTED
Syros Pharmaceuticals, Inc. Common Stock
SYRS
| $18.7K | ﹤0.01% |
81,460
+52,626
| +183% | +$12.1K |
|
2045
Gold Resource Corp
GORO
$114M
| $18.5K | ﹤0.01% |
80,441
+60,405
| +301% | +$13.9K |
|
2046
Urgent.ly
ULY
$5.57M
| $18.5K | ﹤0.01% |
+3,019
| New | +$18.5K |
|
2047
Cenntro
CENN
$28.4M
| $18.4K | ﹤0.01% |
17,204
+68
| +0.4% | +$73 |
|
2048
DURECT Corp
DRRX
$59.3M
| $18.4K | ﹤0.01% |
24,501
+3,665
| +18% | +$2.75K |
|
2049
Rani Therapeutics
RANI
$24.2M
| $17.7K | ﹤0.01% |
+12,890
| New | +$17.7K |
|
2050
Future FinTech Group
FTFT
$9.14M
| $17.6K | ﹤0.01% |
5,685
+3,393
| +148% | +$10.5K |
|